Fig. 4
From: AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo
In vivo cardiac functional improvement of Mybpc3-KO mouse model via i.p. administration of 2.5 mg and 10 mg AZD2014. Echocardiography-based quantification of cardiac functional improvement-related parameters in Mybpc3-KO mice from different treatment groups. n = 5, animal per group, mean ± S.D., *; p < 0.05 vs. KO (by one-way ANOVA)